Literature DB >> 8662985

Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase.

A M Gardner1, G L Johnson.   

Abstract

Treatment of L929 cells with tumor necrosis factor alpha (TNFalpha) activates a programmed cell death pathway resulting in apoptosis. We investigated the intracellular signaling pathways activated in L929 cells by TNFalpha. TNFalpha robustly activates Jun kinase (JNK), a member of the mitogen-activated protein kinase (MAPK) family. In addition, p42(MAPK) is activated, but a 10-fold greater concentration of TNFalpha was required for substantial MAPK activation than was needed for maximal JNK stimulation. Simultaneous treatment of L929 cells with fibroblast growth factor (FGF-2) significantly reduced the apoptotic response to TNFalpha. FGF-2 substantially activated the Raf/MEK/MAPK (where MEK is mitogen-activated protein kinase kinase) pathway but did not affect TNFalpha activation of JNK. These results indicate that although JNK may play an important role in transmitting the TNFalpha signal from the cell surface to the nucleus, activation of the JNK pathway is not sufficient to induce apoptosis. Expression of dominant-negative Asn-17 Ras in L929 cells diminished the FGF-2 stimulation of p42(MAPK) and eliminated the protective effect of FGF-2. Asn-17 Ras expression did not affect JNK activity and had no effect on TNFalpha activation of JNK. Pharmacological inhibition of MEK-1 activity by incubation of cells with the compound PD 098059 blocked p42(MAPK) activation and FGF-2 protection against apoptosis. Interestingly, activated Val-12 Ras expression substantially enhanced TNFalpha-mediated apoptosis in L929 cells, but Val-12 Ras did not constitutively activate MAPK in L929 cells and FGF-2 partially protected Val-12 Ras-expressing cells from TNFalpha-mediated apoptosis. Our data indicate that activation of the MAPK pathway mediates an FGF-2 protective effect against apoptosis and highlights the important role that integration of multiple intracellular signaling pathways plays in the regulation of cell growth and death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662985     DOI: 10.1074/jbc.271.24.14560

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway.

Authors:  P Erhardt; E J Schremser; G M Cooper
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis.

Authors:  T H Holmström; S E Tran; V L Johnson; N G Ahn; S C Chow; J E Eriksson
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal.

Authors:  M Le Gall; J C Chambard; J P Breittmayer; D Grall; J Pouysségur; E Van Obberghen-Schilling
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

4.  Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells.

Authors:  A Danilkovitch; S Donley; A Skeel; E J Leonard
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells.

Authors:  D Saha; P K Datta; H Sheng; J D Morrow; M Wada; H L Moses; R D Beauchamp
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

6.  Elevated fibroblast growth factor-2 increases tumor necrosis factor-alpha induced endothelial cell death in high glucose.

Authors:  Alisa Morss Clyne; Han Zhu; Elazer R Edelman
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

7.  Attenuation of ischemia/reperfusion induced MAP kinases by N-acetyl cysteine, sodium nitroprusside and phosphoramidon.

Authors:  A Mehta; C P S Sekhon; S Giri; J K Orak; A K Singh
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

8.  Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway.

Authors:  A C Maroney; M A Glicksman; A N Basma; K M Walton; E Knight; C A Murphy; B A Bartlett; J P Finn; T Angeles; Y Matsuda; N T Neff; C A Dionne
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

9.  RETRACTED: Identification of phosphorylated p38 as a novel DAPK-interacting partner during TNFalpha-induced apoptosis in colorectal tumor cells.

Authors:  Khuloud Bajbouj; Angela Poehlmann; Doerthe Kuester; Thomas Drewes; Kathrin Haase; Roland Hartig; Anne Teller; Stefanie Kliche; Diana Walluscheck; Jelena Ivanovska; Saritha Chakilam; Annika Ulitzsch; Ursula Bommhardt; Martin Leverkus; Albert Roessner; Regine Schneider-Stock
Journal:  Am J Pathol       Date:  2009-07-23       Impact factor: 4.307

10.  Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1.

Authors:  HongSeob So; HyungJin Kim; Yunha Kim; Eunsook Kim; Hyun-Ock Pae; Hun-Taeg Chung; Hye-Jung Kim; Kang-Beom Kwon; Kang-Min Lee; Haa-Yung Lee; Sung-Kyun Moon; Raekil Park
Journal:  J Assoc Res Otolaryngol       Date:  2008-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.